BRUKER CORP (BRKR) Stock Fundamental Analysis
NASDAQ:BRKR - US1167941087 - Common Stock
33.23 USD
-0.75 (-2.21%)
30 USD
-3.23 (-9.72%)
We assign a fundamental rating of 5 out of 10 to BRKR. BRKR was compared to 55 industry peers in the Life Sciences Tools & Services industry. BRKR has a medium profitability rating, but doesn't score so well on its financial health evaluation. BRKR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
BRKR had positive earnings in the past year.
In the past year BRKR had a positive cash flow from operations.
Each year in the past 5 years BRKR has been profitable.
In the past 5 years BRKR always reported a positive cash flow from operatings.
1.2 Ratios
BRKR has a better Return On Assets (1.26%) than 65.45% of its industry peers.
BRKR has a Return On Equity of 4.41%. This is in the better half of the industry: BRKR outperforms 69.09% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.48%, BRKR is in the better half of the industry, outperforming 67.27% of the companies in the same industry.
BRKR had an Average Return On Invested Capital over the past 3 years of 9.30%. This is significantly below the industry average of 15.96%.
The 3 year average ROIC (9.30%) for BRKR is well above the current ROIC(4.48%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROIC | 4.48% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
BRKR's Profit Margin of 2.31% is fine compared to the rest of the industry. BRKR outperforms 65.45% of its industry peers.
In the last couple of years the Profit Margin of BRKR has declined.
The Operating Margin of BRKR (9.69%) is better than 67.27% of its industry peers.
In the last couple of years the Operating Margin of BRKR has declined.
BRKR's Gross Margin of 48.54% is in line compared to the rest of the industry. BRKR outperforms 49.09% of its industry peers.
In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
BRKR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BRKR has been increased compared to 1 year ago.
The number of shares outstanding for BRKR has been reduced compared to 5 years ago.
The debt/assets ratio for BRKR is higher compared to a year ago.
2.2 Solvency
BRKR has an Altman-Z score of 2.07. This is not the best score and indicates that BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
BRKR has a Altman-Z score (2.07) which is comparable to the rest of the industry.
BRKR has a debt to FCF ratio of 49.40. This is a negative value and a sign of low solvency as BRKR would need 49.40 years to pay back of all of its debts.
The Debt to FCF ratio of BRKR (49.40) is comparable to the rest of the industry.
BRKR has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
BRKR has a worse Debt to Equity ratio (1.32) than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Altman-Z | 2.07 |
ROIC/WACC0.47
WACC9.46%
2.3 Liquidity
BRKR has a Current Ratio of 1.61. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
BRKR has a Current ratio of 1.61. This is in the lower half of the industry: BRKR underperforms 70.91% of its industry peers.
BRKR has a Quick Ratio of 1.61. This is a bad value and indicates that BRKR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.68, BRKR is doing worse than 90.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 |
3. Growth
3.1 Past
BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.99%.
BRKR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
The Revenue has grown by 10.36% in the past year. This is quite good.
The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
3.2 Future
BRKR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.50% yearly.
BRKR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.25% yearly.
EPS Next Y-14.84%
EPS Next 2Y0.75%
EPS Next 3Y5.98%
EPS Next 5Y9.5%
Revenue Next Year2.95%
Revenue Next 2Y2.44%
Revenue Next 3Y3.47%
Revenue Next 5Y3.25%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 15.46, the valuation of BRKR can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 92.73% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.90. BRKR is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 13.58 indicates a correct valuation of BRKR.
92.73% of the companies in the same industry are more expensive than BRKR, based on the Price/Forward Earnings ratio.
BRKR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.52.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.46 | ||
| Fwd PE | 13.58 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRKR is valued cheaper than 87.27% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as BRKR.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 102.26 | ||
| EV/EBITDA | 13.58 |
4.3 Compensation for Growth
The decent profitability rating of BRKR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.73
EPS Next 2Y0.75%
EPS Next 3Y5.98%
5. Dividend
5.1 Amount
With a yearly dividend of 0.60%, BRKR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.54, BRKR pays a better dividend. On top of this BRKR pays more dividend than 94.55% of the companies listed in the same industry.
With a Dividend Yield of 0.60, BRKR pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.6% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
38.32% of the earnings are spent on dividend by BRKR. This is a low number and sustainable payout ratio.
BRKR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP38.32%
EPS Next 2Y0.75%
EPS Next 3Y5.98%
33.23
-0.75 (-2.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners82.53%
Inst Owner Change3.05%
Ins Owners26.98%
Ins Owner Change0.2%
Market Cap5.04B
Analysts76.19
Price Target45.93 (38.22%)
Short Float %6.44%
Short Ratio2.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.6% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP38.32%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.72%
Min EPS beat(2)-26.01%
Max EPS beat(2)6.57%
EPS beat(4)2
Avg EPS beat(4)-4.79%
Min EPS beat(4)-26.01%
Max EPS beat(4)6.57%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)9
Avg EPS beat(12)4.53%
EPS beat(16)11
Avg EPS beat(16)6.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)2.76%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)0.99%
PT rev (1m)-13.45%
PT rev (3m)-22.95%
EPS NQ rev (1m)-46.54%
EPS NQ rev (3m)-52.5%
EPS NY rev (1m)-17.43%
EPS NY rev (3m)-18.34%
Revenue NQ rev (1m)-3.9%
Revenue NQ rev (3m)-3.74%
Revenue NY rev (1m)-1.78%
Revenue NY rev (3m)-1.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.46 | ||
| Fwd PE | 13.58 | ||
| P/S | 1.46 | ||
| P/FCF | 102.26 | ||
| P/OCF | 30.39 | ||
| P/B | 2.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.58 |
EPS(TTM)2.15
EY6.47%
EPS(NY)2.45
Fwd EY7.36%
FCF(TTM)0.32
FCFY0.98%
OCF(TTM)1.09
OCFY3.29%
SpS22.69
BVpS11.89
TBVpS-5.37
PEG (NY)N/A
PEG (5Y)1.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROCE | 6.68% | ||
| ROIC | 4.48% | ||
| ROICexc | 4.57% | ||
| ROICexgc | 9.81% | ||
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% | ||
| FCFM | 1.43% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Debt/EBITDA | 4.37 | ||
| Cap/Depr | 55.42% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.5% | ||
| Profit Quality | 61.93% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 | ||
| Altman-Z | 2.07 |
F-Score5
WACC9.46%
ROIC/WACC0.47
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
EPS Next Y-14.84%
EPS Next 2Y0.75%
EPS Next 3Y5.98%
EPS Next 5Y9.5%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
Revenue Next Year2.95%
Revenue Next 2Y2.44%
Revenue Next 3Y3.47%
Revenue Next 5Y3.25%
EBIT growth 1Y-20.95%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year20.83%
EBIT Next 3Y14.44%
EBIT Next 5Y8.69%
FCF growth 1Y-75.44%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-51.42%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%